Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Pharmacology Reports|February 7, 2018
Pancreatic cancer: Current status and ChallengesAmanda R Muñoz, Divya Chakravarthy, Jingjing Gong, et al.
Cancer Letters|February 8, 2018
Palmatine suppresses glutamine-mediated interaction between pancreatic cancer and stellate cells through simultaneous inhibition of survivin and COL1A1Divya Chakravarthy, Amanda R Muñoz, Angel Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2014
Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancerJingjing Gong, Jianping Xie, Roble Bedolla, et al.
Blood Advances|October 17, 2024
Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapyGeoffrey L Uy, Vinod Pullarkat, Praneeth Baratam, et al.
Blood Neoplasia|September 11, 2025
V-FAST: a phase 1b master trial to investigate CPX-351 combined with targeted agents in adults with newly diagnosed AMLVinod A Pullarkat, Mark Levis, James McCloskey, et al.
International Journal of Molecular Sciences|March 6, 2021
Evidence for 2-Methoxyestradiol-Mediated Inhibition of Receptor Tyrosine Kinase RON in the Management of Prostate CancerIzhar Singh Batth, Shih-Bo Huang, Michelle Villarreal, et al.
Pageof 1